Staphylococcal enterotoxins (SEs) are emetic toxins that cause the intoxication staphylococcal food poisoning syndrome. In addition to causing emesis, the SEs have a number of other biological activities. The SEs interact with T cell receptors in the presence of class II major histocompatibility antigens resulting in T cell proliferation and release of cytokines (mimicking the Mls-1 response). At the molecular level very little is known about the SE's mechanism of action for any of these biological activities; the relationship between emesis and T cell-macrophage interaction is not clear. The significance of the SE's immunological properties is not well understood. But there is epidemiological and experimental evidence showing that the SEs are important virulence factors in some Toxic Shock Syndrome cases and many of the symptoms may be due to SE induced cytokine secretion. I am taking molecular biological and biochemical approaches to elucidate the relationship between SE's structure and function because very little is known. This proposal has two parts. (Specific Aim #1) A map of staphylococcal enterotoxin type A (SEA) will be constructed that defines peptide domains that are and are not required for SEA's various biological activity. This will be done using molecular biological techniques to construct Ma mutations and assaying the resulting altered-SEA for their -biological activities. (Specific Aim #2) The structure of SEA will be solved by x-ray diffraction analysis of crystals. Detailed structure-activity information obtained from the proposed research will be necessary for elucidation of the molecular mechanism for SEA's biological activities which include understanding immune system biology and may have applications for understanding some neurological-hormonal interactions. In addition, information from these studies could lead to development of SEA based therapeutic agents that are immunopotentiating agents.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI025574-04A1
Application #
3139038
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1988-02-01
Project End
1996-07-31
Budget Start
1991-08-01
Budget End
1992-07-31
Support Year
4
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
Schools of Earth Sciences/Natur
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Hoffman, M; Tremaine, M; Mansfield, J et al. (1996) Biochemical and mutational analysis of the histidine residues of staphylococcal enterotoxin A. Infect Immun 64:885-90
Harris, T O; Betley, M J (1995) Biological activities of staphylococcal enterotoxin type A mutants with N-terminal substitutions. Infect Immun 63:2133-40
Rao, L; Karls, R K; Betley, M J (1995) In vitro transcription of pathogenesis-related genes by purified RNA polymerase from Staphylococcus aureus. J Bacteriol 177:2609-14
Harris, T O; Hufnagle, W O; Betley, M J (1993) Staphylococcal enterotoxin type A internal deletion mutants: serological activity and induction of T-cell proliferation. Infect Immun 61:2059-68
Harris, T O; Grossman, D; Kappler, J W et al. (1993) Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins. Infect Immun 61:3175-83
Tremaine, M T; Brockman, D K; Betley, M J (1993) Staphylococcal enterotoxin A gene (sea) expression is not affected by the accessory gene regulator (agr). Infect Immun 61:356-9
Betley, M J; Borst, D W; Regassa, L B (1992) Staphylococcal enterotoxins, toxic shock syndrome toxin and streptococcal pyrogenic exotoxins: a comparative study of their molecular biology. Chem Immunol 55:1-35
Grossman, D; Lamphear, J G; Mollick, J A et al. (1992) Dual roles for class II major histocompatibility complex molecules in staphylococcal enterotoxin-induced cytokine production and in vivo toxicity. Infect Immun 60:5190-6
Hufnagle, W O; Tremaine, M T; Betley, M J (1991) The carboxyl-terminal region of staphylococcal enterotoxin type A is required for a fully active molecule. Infect Immun 59:2126-34
Soltis, M T; Mekalanos, J J; Betley, M J (1990) Identification of a bacteriophage containing a silent staphylococcal variant enterotoxin gene (sezA+). Infect Immun 58:1614-9

Showing the most recent 10 out of 11 publications